
|
BIOGRAPHICAL SKETCH
SUBHASH POPLI, M.D.
Chief, Renal & Hypertension Section
Associate Professor
|
Medical Service (111L)
VA Hospital
Hines, IL 60141
(708) 202-2781
|
Loyola University Medical Center
Department of Medicine
2160 S. First Avenue
Maywood, IL 60153
|
Academic & Professional Background
- Pre-Medical 1964 - Mohindra College, Patiala, India
- M.B.B.S. 1970 - Government Medical College, Patiala, India
- Internship 1970 - Rajindra Hospital, Patiala, India
- House Staff 1972 - Rajindra Hospital, Patiala, India
- E.C.F.M.G. 1973
- Residency (Internal Medicine) 1976 - VA Hospital, Hines, Illinois
- Fellowship (Nephrology) 1978 - VA Hospital, Hines, Illinois
- Certification, American Board Internal Medicine & Nephrology 1977 & 1978
Current Research Interests
- Dialysis Ascites
- Hyperosmolality and Hyperglycemia in Patients with Renal Insufficiency and Dialysis
- Hypertension
- Uremic Pericarditis
Selected Publications
Sahani MM, Mukhtar KN, Boorgu R, Leehey DJ, Popli S, Ing TS. Tissue plasminogen activator can effectively declot peritoneal dialysis catheters. Amer J Kidney Dis 36(3), 2000.
Popli S, Ing TS, Vaziri ND. Cardiovascular consequences of rapid hemodialysis. In: Vascular Access Surgery, 4th ed., Wilson SE (ed.). Mosby-Year Book, Inc., St. Louis, MO pp. 216-233, 2002.
Popli S, Ing TS, Vaziri ND. Cardiovascular consequences of rapid hemodialysis. In: Vascular Access Surgery, 3rd Edition. Wilson SE (Ed.). Mosby-Year Book, Inc., St. Louis, MO pp. 225-233, 1996.
Popli S, Leehey DJ, Giacciano JL, Ramamurthy S, Soundararajan R, Ing TS. Obstruction to venous outflow from the left lower extremity after renal transplantation. Clin Nephrol 45(1), 1996.
Popli S, Ejaz AA, Ing TS. Cyclosporine and metal ion interaction in body fluids. In: Handbook of Metal-Ligand Interaction in Biological Fluids, Bioinorganic Medicine. Berthon G (Ed.). Marcel Dekkar, Inc., New York pp. 1471-1478, 1995.
Projects Completed or Active (Selected)
- A One Year Open Label, Positive Controlled Trial of Carvedilol Administered Twice Daily in Patients with Mild Hypertension. Smith Klein and French, Inc
- A Multi-Center Comparison of Cefoperazone/Sulbactam with Ticarcillin/Clavulanic Acid in the Treatment of Complicated Urinary Tract Infections. Pfizer Company
- Hypertension Optimal Treatment (HOT) International Study
- A Triple-Blind, Parallel Study to Investigatore the Effect of Losartan versus Atenolol on the Reduction to Morbidity and Mortality in Hypertensive Patients with Left Ventricular Hypertrophy
- Controlled Onset Varapamil Investigation of Cardiovascular Endpoints (CONVINCE)
- A Randomized Study of Prostatic Surgery for Moderately Symptomatic Benight Prostatic Hyperplasia in Elderly Men
- Homocysteinemia in Kidney and End Stage Renal Disease (HOST)
Research Funding Sources
- Smith-Kline and French, Inc.
- Pfizer Company
- Astra Merck
- Merck Sharp & Dohme
- JD Searle
- VA Cooperative Studies
Honors
- 1981 - Fellow, American College of Physicians
|

|